A Reflection of ESMO

By Fabienne Wild

Blog

Client Relationship Director Fabienne Wild reflects on the recent conference season and on her experience at the European Society for Medical Oncology (ESMO).

As autumn is now in full swing, the vibrant colour change of the surrounding foliage is a fitting reflection for the end of a vibrant and very busy conference season.
The European Society for Medical Oncology (ESMO) from 19 – 23 October formed the end of the queue, and as this year it was held in my home town of Munich, it was a great opportunity for me to meet with our clients and start fascinating conversations with new people.

The objective for this congress is for HCPs to learn from physicians and scientists who present their research in prostate, bladder, and kidney cancer. It is the home for all oncology stakeholders, connecting professionals with diverse expertise and experience, and speaking with one voice for the discipline.

As Ashfield Meetings & Events, our teams of logistics and exhibit experts from our EU and US offices joined the 19,000 oncology professionals from over 150 countries for this important event highlighting the ground-breaking research in cancer care. We had the pleasure of hosting 950 attendees through six of our clients and we designed and delivered two of the exhibition booths and created a hospitality suite.

Our experience in managing attendance at congresses and conventions on behalf of our clients spans over 30 years, so we’re well-versed in advising on what’s required at a congress, and how to make their attendance and experience more impactful and effective. But it was great to have the opportunity to hear first-hand just how much our clients valued the wealth and breadth of our understanding of this type of event – from the logistics of the delegates, right through to the creation and influence of their exhibition booths.

ESMO was a very exciting and informative occasion. Not only did HCPs get to connect and engage with the experts in their field to discover the latest learnings and practices, but our clients got to demonstrate just how their vital research and advancements in treatments are playing a major role in the fight against this horrendous disease.

How incredibly rewarding knowing that we played a part in enabling them to get these messages across – in the best and most memorable way possible – to the HCPs who need to know them. It’s our way of ultimately helping to improve the lives of patients and we’re very proud of the part we play.

Related Articles